Please use this identifier to cite or link to this item:
Title: Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance.
Austin Authors: Wong, Lih-Ming ;Koschel, Samantha;Whish-Wilson, Thomas;Farag, Matthew ;Bolton, Damien M ;Zargar, Homi;Corcoran, Niall;Lawrentschuk, Nathan;Christov, Alexandar;Thomas, Lauren;Perry, Elisa;Heinze, Stefan;Taubman, Kim;Sutherland, Tom
Affiliation: Department of Urology, St Vincent's Health Melbourne, Melbourne, Australia.
Department of Surgery, University of Melbourne, Melbourne, Australia.
Department of Radiology, St Vincent's Health Melbourne, Melbourne, Australia.
Department of Radiology, Melbourne Health, Melbourne, Australia.
Issue Date: 5-Jan-2023
Date: 2023
Publication information: World Journal of Urology 2023, 41(2)
Abstract: To determine the utility of diagnostic 18F-DCPyL PSMA-PET/CT to aid management of men with highly suspicious multiparametric MRI prostate (PIRAD 4-5 lesions) and discrepant negative prostate biopsy.
DOI: 10.1007/s00345-022-04243-5
ORCID: 0000-0003-0490-7876
Journal: World Journal of Urology
PubMed URL: 36602577
ISSN: 1433-8726
Type: Journal Article
Subjects: 18F-DCPyL
Prostate biopsy
Prostate cancer
mpMRI prostate
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Sep 29, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.